114 related articles for article (PubMed ID: 37994899)
41. Identification of UAP1L1 as a critical factor for protein O-GlcNAcylation and cell proliferation in human hepatoma cells.
Lai CY; Liu H; Tin KX; Huang Y; Yeh KH; Peng HW; Chen HD; He JY; Chiang YJ; Liu CS; Weng SY; Tao MH; Yen JJ; Yang-Yen HF
Oncogene; 2019 Jan; 38(3):317-331. PubMed ID: 30097606
[TBL] [Abstract][Full Text] [Related]
42. Targeting USP8 Inhibits O-GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT.
Tang J; Long G; Hu K; Xiao D; Liu S; Xiao L; Zhou L; Tao Y
Adv Sci (Weinh); 2023 Nov; 10(33):e2302953. PubMed ID: 37867237
[TBL] [Abstract][Full Text] [Related]
43. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
[TBL] [Abstract][Full Text] [Related]
44. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
[TBL] [Abstract][Full Text] [Related]
45. Gluconeogenic enzyme PCK1 deficiency promotes CHK2 O-GlcNAcylation and hepatocellular carcinoma growth upon glucose deprivation.
Xiang J; Chen C; Liu R; Gou D; Chang L; Deng H; Gao Q; Zhang W; Tuo L; Pan X; Liang L; Xia J; Huang L; Yao K; Wang B; Hu Z; Huang A; Wang K; Tang N
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33690219
[TBL] [Abstract][Full Text] [Related]
46. Regulatory factor X5 promotes hepatocellular carcinoma progression by transactivating tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta and suppressing apoptosis.
Chen DB; Zhao YJ; Wang XY; Liao WJ; Chen P; Deng KJ; Cong X; Fei R; Wu X; Shao QX; Wei L; Xie XW; Chen HS
Chin Med J (Engl); 2019 Jul; 132(13):1572-1581. PubMed ID: 31188160
[TBL] [Abstract][Full Text] [Related]
47. Personalized neoantigen vaccine combined with PD-1 blockade increases CD8
Chen H; Li Z; Qiu L; Dong X; Chen G; Shi Y; Cai L; Liu W; Ye H; Zhou Y; Ouyang J; Cai Z; Liu X
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36113894
[TBL] [Abstract][Full Text] [Related]
48. Suppressed OGT expression inhibits cell proliferation while inducing cell apoptosis in bladder cancer.
Wang L; Chen S; Zhang Z; Zhang J; Mao S; Zheng J; Xuan Y; Liu M; Cai K; Zhang W; Guo Y; Zhai W; Yao X
BMC Cancer; 2018 Nov; 18(1):1141. PubMed ID: 30453909
[TBL] [Abstract][Full Text] [Related]
49. MiR-101 and doxorubicin codelivered by liposomes suppressing malignant properties of hepatocellular carcinoma.
Xu F; Liao JZ; Xiang GY; Zhao PX; Ye F; Zhao Q; He XX
Cancer Med; 2017 Mar; 6(3):651-661. PubMed ID: 28135055
[TBL] [Abstract][Full Text] [Related]
50. Suppressed OGT expression inhibits cell proliferation and modulates EGFR expression in renal cell carcinoma.
Wang L; Chen S; Zhang J; Mao S; Mao W; Zhang W; Guo Y; Wu Y; Wang R; Yan Y; Yao X
Cancer Manag Res; 2019; 11():2215-2223. PubMed ID: 30962710
[TBL] [Abstract][Full Text] [Related]
51. Sublethal heat stress-induced O-GlcNAcylation coordinates the Warburg effect to promote hepatocellular carcinoma recurrence and metastasis after thermal ablation.
Chen Y; Bei J; Liu M; Huang J; Xie L; Huang W; Cai M; Guo Y; Lin L; Zhu K
Cancer Lett; 2021 Oct; 518():23-34. PubMed ID: 34126196
[TBL] [Abstract][Full Text] [Related]
52. Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model.
Wang C; Gao D; Guo K; Kang X; Jiang K; Sun C; Li Y; Sun L; Shu H; Jin G; Sun H; Wu W; Liu Y
BMC Cancer; 2012 May; 12():166. PubMed ID: 22559167
[TBL] [Abstract][Full Text] [Related]
53. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1) suppressed the growth of hepatocellular carcinoma cells by promoting Semaphorin 3B(SEMA3B).
Hu J; Duan B; Jiang W; Fu S; Gao H; Lu L
Cancer Med; 2019 Jun; 8(6):3152-3166. PubMed ID: 30972979
[TBL] [Abstract][Full Text] [Related]
54. Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice.
Zhao W; Zhang L; Yin Z; Su W; Ren G; Zhou C; You J; Fan J; Wang X
Int J Cancer; 2011 Dec; 129(11):2651-61. PubMed ID: 21213212
[TBL] [Abstract][Full Text] [Related]
55. Golgi membrane protein GP73 modified-liposome mediates the antitumor effect of survivin promoter-driven HSVtk in hepatocellular carcinoma.
Liu C; Wen C; Wang X; Wei Y; Xu C; Mu X; Zhang L; Wang X; Tian J; Ma P; Meng F; Zhang Q; Zhao N; Yu B; Gong T; Guo R; Wang H; Xie J; Sun G; Li G; Zhang H; Qin Q; Xu J; Dong X; Wang L
Exp Cell Res; 2019 Oct; 383(1):111496. PubMed ID: 31306654
[TBL] [Abstract][Full Text] [Related]
56. An Application of Tumor-Associated Macrophages as Immunotherapy Targets: Sialic Acid-Modified EPI-Loaded Liposomes Inhibit Breast Cancer Metastasis.
Meng X; Wang M; Zhang K; Sui D; Chen M; Xu Z; Guo T; Liu X; Deng Y; Song Y
AAPS PharmSciTech; 2022 Oct; 23(8):285. PubMed ID: 36258152
[TBL] [Abstract][Full Text] [Related]
57. Combination therapy with anti-T-cell immunoglobulin and mucin-domain containing molecule 3 and radiation improves antitumor efficacy in murine hepatocellular carcinoma.
Kim KJ; Lee HW; Seong J
J Gastroenterol Hepatol; 2021 May; 36(5):1357-1365. PubMed ID: 33217056
[TBL] [Abstract][Full Text] [Related]
58. Mechanisms and network pharmacological analysis of Yangyin Fuzheng Jiedu prescription in the treatment of hepatocellular carcinoma.
Xie Y; Yan F; Wang X; Yu L; Yan H; Pu Q; Li W; Yang Z
Cancer Med; 2023 Feb; 12(3):3237-3259. PubMed ID: 36043445
[TBL] [Abstract][Full Text] [Related]
59. Design of OSMI-4 Analogs Using Scaffold Hopping: Investigating the Importance of the Uridine Mimic in the Binding of OGT Inhibitors.
Balsollier C; Tomašič T; Yasini D; Bijkerk S; Anderluh M; Pieters RJ
ChemMedChem; 2023 Apr; 18(8):e202300001. PubMed ID: 36752318
[TBL] [Abstract][Full Text] [Related]
60. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
